Nitric Oxide Bioavailability
Nitric Oxide Bioavailability is a physiological construct that denotes the net concentration of biologically active nitric oxide available in the vascular endothelium at any given time, determined by the dynamic balance between its synthesis from endothelial nitric oxide synthase and its inactivation by reactive oxygen species, thereby governing vasodilation, anti-inflammatory responses, and microcirculatory perfusion.
987
Publications
71.3K
Citations
5.3K
Authors
1.3K
Institutions
Publications per year
2017–2026
215
987
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Ulrich Hink, Huige Li, Hanke Mollnau et al. · Circulation Research · 2001 · 1.2K citations
Medicine, Biochemistry, Pharmacology +16
Endogenous Nitric Oxide Synthase Inhibitor
Hiroshi Miyazaki, Hidehiro Matsuoka, John P. Cooke et al. · Circulation · 1999 · 764 citations · Full text
Medicine, Cardiology, Pharmacology +15
1–5 of 987
5.3K
17
h-index
15
h-index
13
h-index
13
h-index
12
h-index
1–5 of 5.3K
1.3K
Universidade de São Paulo
São Paulo, Brazil
20 h-index
110 publications
4.5K citations

Karolinska Institutet
Stockholm, Sweden
18 h-index
102 publications
8.3K citations
National Heart Lung and Blood Institute
Bethesda, United States
17 h-index
74 publications
13.9K citations
University of Utah
Salt Lake City, United States
17 h-index
102 publications
5.2K citations
Emory University
Atlanta, United States
16 h-index
57 publications
20.5K citations

Brigham and Women's Hospital
Boston, United States
15 h-index
41 publications
8.8K citations

John Radcliffe Hospital
Oxford, United Kingdom
15 h-index
90 publications
17.9K citations
Harvard University
Cambridge, United States
15 h-index
34 publications
6.3K citations
1–8 of 1.3K
40 publications · 8K citations
40
h-index
56 publications · 4.3K citations
35
h-index
32 publications · 2.9K citations
28
h-index
29 publications · 1.3K citations
23
h-index
26 publications · 1.6K citations
18
h-index
1–5